Skip to main content
. 2026 Jan 8;27:19. doi: 10.1186/s13063-026-09424-w

Fig. 3.

Fig. 3

Bladder cancer trial characteristics cross-tabulated with health status eligibility criteria (**p < 0.01, Fisher’s exact test). AD n = 38 trials. E n = 22 trials (trials in non-metastatic setting excluded from analysis)